đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
AD17002 has demonstrated superior safety and efficacy as a nasal adjuvant f...
Status
Completed
Location
Advagene Biopharma
Start Date
2022-03-21
Trial ID
NCT05069610
Treatments Being Tested
This study aims to assess the feasibility, tolerability, and exploratory ef...
Status
Completed
Location
Radboud University Medical Center
Start Date
2026-04-30
Trial ID
NCT07532577
Treatments Being Tested
The purpose of this study is to determine if the investigational drug is ef...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-03
Trial ID
NCT00107757
Treatments Being Tested
The purpose of this study is to find out if different doses of Investigatio...
Status
Completed
Location
Pivotal Research
Start Date
2007-01
Trial ID
NCT00422981
This is a Phase 2 study assessing the safety, tolerability and efficacy of ...
Status
Unknown
Location
Multiple Locations
Start Date
2023-06
Trial ID
NCT03806478
The aim of the study is to investigate the trial models, Vienna Challenge C...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-03
Trial ID
NCT00400998
Treatments Being Tested
EFC18418 is a multinational, randomized, double-blind, placebo-controlled, ...
Status
Active Not Recruiting
Location
University of Southern California (USC) / Keck Medicine of USC- Site Number : 8400037
Start Date
2025-02-12
Trial ID
NCT06834347
Treatments Being Tested
The purpose of this study is to determine if the use of ketamine, sniffed i...
Status
Unknown
Location
Mbingo Baptist Hospital
Start Date
2015-12
Trial ID
NCT02573714
A total of 96 subjects will be recruited into 5 groups. Each subject will r...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-09
Trial ID
NCT02864628
Treatments Being Tested